Related Experiment Video
Updated: Aug 19, 2026

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
[Serial changes in serum CA 19-9 levels in pancreatic cancer]
Abstract:
Levels of a new carbohydrate antigen CA 19-9, which is a monosialoganglioside identified by a monoclonal antibody, were measured in 41 patients with pancreatic cancer and these serial changes were investigated. To provide a contrast, the serum CEA levels were compared with the serum CA 19-9 levels. As the result of this study, it was found that the serial changes of the serum levels of CA 19-9 were more correlative to the clinical course of these patients with pancreatic cancer than those of the serum CEA levels.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Serum Laboratory Studies, Stool Test, Breath Test
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology

